Figure 2
From: Survival analysis of localized prostate cancer with deep learning
Patient selection flowchart. After gathering all prostate cancer patients diagnosed between 2001-2017 in the VA cancer registry, we have excluded patients satisfying any of the following criteria: (1) late-stage (metastasized) prostate cancer or having other types of cancer at the time of diagnosis, (2) no valid PSA test 1 year before diagnosis, (3) no valid Gleason score (Unknown or \(<6\)), and (4) no biopsy record for diagnosis.
